文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

农村阿巴拉契亚地区COVID-19感染ICU患者的死亡率:凸显医疗差距

ICU Mortality in Patients With Coronavirus Disease 2019 Infection: Highlighting Healthcare Disparities in Rural Appalachia.
PubMed 文献 · Crit Care Explor · 2021-10-08
一句话结论从农村关键接入医院转至三级ICU的COVID-19 ARDS患者30天死亡率显著高于非COVID-19 ARDS对照组(68% vs 42%,p=0.034)。

对照组为39例非COVID-19 ARDS并插管机械通气的ICU患者。COVID-19组30天死亡率显著高于对照组(68% vs 42%,p=0.034),两组SOFA评分相似。70岁及以上插管和机械通气超过5天与显著更高的死亡率相关。提示农村地区缺乏或延迟获得三级诊疗可能影响COVID-19结局。

要点

  • 从农村关键接入医院/农村机构转入三级ICU的COVID-19 ARDS并机械通气患者30天死亡率为68%,显著高于非COVID-19 ARDS对照组的42%(p=0.034)。
  • 两组平均SOFA评分相似,提示死亡率差异不能仅用入ICU时器官功能障碍严重程度解释。
  • 70岁及以上插管患者和机械通气超过5天的患者死亡率显著更高。
  • 研究期间该ICU共收治79例连续COVID-19患者,总死亡率为54%。
  • 作者提出农村地区缺乏或延迟获得三级诊疗可能影响COVID-19结局,数据或有助于农村地区优化有限资源利用。

适用人群与场景

  • 其中50例为从农村关键接入医院/农村机构转入的COVID-19诱导ARDS患者。
  • 对照组为39例因非COVID-19 ARDS入住ICU并插管机械通气的患者。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 70岁及以上且接受插管的患者死亡率显著更高。
  • 机械通气超过5天的患者死亡率显著更高。

研究设计与关键结果

  • 研究类型:回顾性病例对照研究,单中心(西弗吉尼亚大学医院ICU),连续纳入79例COVID-19成人患者,其中50例为从农村关键接入医院/农村机构转入的COVID-19诱导ARDS患者;对照组39例非COVID-19 ARDS插管机械通气患者。
  • 主要终点:全因30天死亡率,COVID-19组显著高于对照组(68% vs 42%,p=0.034)。
  • 两组平均SOFA评分相似。
  • 70岁及以上插管和机械通气超过5天与显著更高的死亡率相关。
  • 研究期间ICU收治的79例连续COVID-19患者总体死亡率为54%。

证据类型、等级与局限

  • 证据类型:回顾性病例对照研究。
  • 局限:单中心、回顾性设计、样本量小(79例COVID-19患者,对照组39例),原文未报告证据等级或推荐强度。

对床旁实践的改变

  • 提示对从农村关键接入医院/农村机构转入的COVID-19 ARDS并机械通气患者,应认识到其30天死亡率可能较高(本队列为68%)。
  • 70岁及以上插管患者和机械通气超过5天者死亡率更高,或可辅助农村地区医生和医院管理者优化有限资源利用。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

UNLABELLED: To assess 30-day mortality in coronavirus disease 2019 acute respiratory distress syndrome patients transferred from rural Appalachian hospitals.

DESIGN: Retrospective case controlled, based on consecutive patients transferred and admitted from rural hospitals to a tertiary-care ICU. The primary outcome was all-cause 30-day mortality. Kaplan-Meier method and log-rank test were used in the survival data analysis.

SETTING: Medical ICU, West Virginia University Hospital, Morgantown, WV.

PATIENTS: All adult patients admitted to the ICU for coronavirus disease 2019 disease between September 30, 2020, and December 2, 2020.

INTERVENTION: Not applicable.

MEASUREMENTS AND MAIN RESULTS: Seventy-nine consecutive coronavirus disease 2019 patients were admitted to the ICU during the defined period. Overall mortality of the cohort was 54%. Of the 79 patients, 50 were transferred from critical access hospitals/rural facilities with coronavirus disease 2019-induced acute respiratory distress syndrome. A control group consisted of 39 patients admitted to the ICU with noncoronavirus disease 2019 acute respiratory distress syndrome who were intubated and mechanically ventilated. Thirty-day mortality in patients with coronavirus disease 2019 admitted to the ICU was significantly higher than the control group (68% vs 42%) (p = 0.034). Mean Sequential Organ Failure Assessment scores were similar in both coronavirus disease 2019 acute respiratory distress syndrome group and controls. Intubation in patients 70 years or older and mechanical ventilation for over 5 days was associated with significantly higher mortality.

CONCLUSIONS: Our data on critically ill and mechanically ventilated coronavirus disease 2019 acute respiratory distress syndrome patients transferred from critical access hospitals/rural facilities have increased mortality compared with noncoronavirus disease 2019 acute respiratory distress syndrome controls. These data suggest that lack or delay in access to tertiary care may impact coronavirus disease 2019 outcome in rural areas. Intubated patients 70 years old or more and mechanical ventilation for over 5 days may be a risk factor for increased mortality. These data may help physicians and hospital administrators in rural areas for optimal utilization of limited resources.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Sharma S, Badami V, Rojas E, et al. ICU Mortality in Patients With Coronavirus Disease 2019 Infection: Highlighting Healthcare Disparities in Rural Appalachia. Crit Care Explor. 2021. PMID: 34651135. doi:10.1097/CCE.0000000000000547

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。